Back to today’s briefing

Story perspectives

WHO Approves R21/Matrix-M Vaccine to Combat Malaria

8/15/2025

48 6

Summary

Story summary

The WHO has approved the R21/Matrix-M malaria vaccine, advancing malaria prevention efforts.
The vaccine produces antibodies akin to those from natural infections, offering robust protection.
Its implementation is expected to lower child mortality rates and enhance healthcare in impacted areas.
Collaboration and innovation played crucial roles in achieving this milestone in global health.

1 of 1

Story summary

The WHO has approved the R21/Matrix-M malaria vaccine, advancing malaria prevention efforts.
The vaccine produces antibodies akin to those from natural infections, offering robust protection.
Its implementation is expected to lower child mortality rates and enhance healthcare in impacted areas.
Collaboration and innovation played crucial roles in achieving this milestone in global health.